|
|
|
|
Brain stimulation benefits cerebral palsy patients
A study has found that deep brain stimulation could improve the quality of life of patients with dystonia-choreoathetosis cerebral palsy.The research, published in The Lancet Neurology, suggests that the treatment could be an...
|
|
|
Deep Brain Stimulation Shows Promising Results For Some Patients With Cerebral Palsy
Deep brain stimulation improves movement skills and quality of life in some patients with a subtype of cerebral palsy (CP) (dystonia-choreoathetosis CP)*, and could be an effective treatment option for these patients, finds an Article...
|
|
|
Deep Brain Stimulation Shows Promise for Some Patients With Cerebral Palsy
-- Deep brain stimulation improves movement skills and quality of life in some patients with dystonia-choreoathetosis cerebral palsy (CP) and could be an effective treatment option for these patients, according to a study published...
|
|
|
Deep Brain Stimulation Shows Promise as Cerebral Palsy Therapy
PRINCETON, N.J., July 2 -- Deep brain stimulation reduced pain and improved movement ability and quality of life for patients with a subtype of cerebral palsy, a new study has found.Action Points Explain to interested patients that a...
|
|
|
Parkinson's Disease Alters Patient's Ability To Learn From Rewards While Treatment Affects Ability To Learn Fr
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.The test was developed by Dr. Mark Gluck, professor of neuroscience...
|
|
|
Medical research: The Parkinson's problem
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.The test was developed by Dr. Mark Gluck, professor of neuroscience...
|
|
|
New findings on Parkinson's disease and effect on patient behavior
Parkinson's disease alters patient's ability to learn from rewards while treatment affects ability to learn from negative outcome -- research reveals possible link to depression, impulse control disorders A new neuropsychological memory test...
|
|
|
New Findings On Parkinson's Disease And Effect On Patient Behavior
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.The test was developed by Dr. Mark Gluck, professor of neuroscience...
|
|
|
New findings on Parkinson's disease and effect on patient behavior
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.The test was developed by Dr. Mark Gluck, professor of neuroscience...
|
|
|
Prevalence of primary focal or segmental dystonia in adults in the district of Foggia, Southern Italy: A servi
; age 18-34 yrs: 39.2; 35-54 yrs: 98.7; 55-74 yrs: 273.6; 75+ yrs: 163.3 Standardized rate: 137.5 Blepharospasm most common clinical condition (prevalence 68.Prevalence of primary focal or segmental dystonia in adults in the...
|
|
|
THAP1 Mutations Found in Many Primary Dystonias
In two new papers, investigators reported that THAP1 mutations may be the leading defects in most cases of primary dystonia.SEATTLE-From a zip code on chromosome 8 found in 1997 in two Amish-Mennonite families with a history of DYT6...
|
|
|
New Data on Memory Molecule Could Benefit Phantom Limb Pain and Other Disorders
Molecules that inhibit PKMzeta apparently cause the disappearance of fully formed long-term memories.Long-term memories may feel as durable as stone, but new research shows they're more like delicate plants that need careful maintenance...
|
|
|
Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative
WASHINGTON, June 19 /PRNewswire/ -- The Center for Laser Surgery, Washington, DC has announced the availability of Dysport, abobotulinum toxin-A.Dysport, recently FDA approved, is the first cosmetic neurotoxin available alongside the...
|
|
|
Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative
WASHINGTON, June 19 /PRNewswire/ -- The Center for Laser Surgery, Washington, DC has announced the availability of Dysport , abobotulinum toxin-A.Dysport, recently FDA approved, is the first cosmetic neurotoxin available alongside the...
|
|
|
Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative
WASHINGTON, June 19 /PRNewswire/ -- The Center for Laser Surgery, Washington, DC has announced the availability of Dysport, abobotulinum toxin-A.Dysport, recently FDA approved, is the first cosmetic neurotoxin available alongside the...
|
|
|
Eisai sets up a subsidiary in Austria
Eisai Co.of Japan has established its new subsidiary, Eisai GesmbH at Vienna, in Austria. Eisai Austria is a subsidiary wholly-owned by Eisai Europe Ltd, UK, and the European subsidiary of Eisai. Eisai entered into the Austrian market...
|
|
|
MDS 2009: Continued Benefit With Pallidal Neurostimulation for Dystonia
_ MDS 2009: Continued Benefit With Pallidal Neurostimulation for Dystonia.
|
|
|
MDS 2009: Continued Benefit With Pallidal Neurostimulation for Dystonia
_ MDS 2009: Continued Benefit With Pallidal Neurostimulation for Dystonia.
|
|
|
Eisai opens subsidiary in Austria
Eisai, one of Japan's top pharma company has opened a new subsidiary in Austria.The new subsidiary, called Eisai GesmbH is based in Austrian capital of Vienna, will be affiliated to Easai's European operations Eisai Europe Limited, which...
|
|
|
[PostScript] Successful GPi deep brain stimulation in a patient with adult onset primary axial dystonia
_ [PostScript] Successful GPi deep brain stimulation in a patient with adult onset primary axial dystonia.
|
|
|
Discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia
Mean TDT in 26 control subjects age <50 yrs of age: 22.85 msMean TDT in 17 controls age <50 yrs: 30.87 ms Upper limit of normal: 42.86 ms in age <50-yr group and 44.Discrimination threshold: VBM evidence for an...
|
|
|
Medicis Begins Shipping Dysport(TM) for Glabellar Lines
(GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company has begun shipment to physicians of DYSPORT(TM) (abobotulinumtoxinA) for the treatment of glabellar lines.DYSPORT is an acetylcholine release inhibitor and a...
|
|
|
Long-Term Use of Botulinum Toxin Type B for Cervical Dystonia Appears Safe: Presented at MDS
-- The results of the longest safety study of botulinum toxin type B (BoNT-B) concluded to date were reported here today at the Movement Disorder Society's (MDS) 13th International Congress of Parkinson's Disease and Movement Disorders.
|
|
|
Merz Pharmaceuticals Announce Three Studies Of NT-201 - (Botulinum Neurotoxin Type A Free From Complexing Prot
Results from three placebo controlled studies conducted to assess NT-201 in upper limb post-stroke spasticity, pre-treated cervical dystonia, and treatment-naive cervical dystonia patients represent the second data set presented...
|
|
|
Merz Pharmaceuticals' Positive Clinical Trials Results For NT-201
To be used in the treatment of upper limb spasticity sufferers of various etiologies Suppliers to this Sector Independent QA for Therapeutic Radiology and Oncol ...From the control room to the downstream processing ... It is our mission...
|
